NOVARTIS HEALTHCARE A/S — Credit Rating and Financial Key Figures
CVR number: 20575786
Edvard Thomsens Vej 14, 2300 København S
skriv.til@pharma.novartis.com
tel: 39168401
Income statement (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 1 002.39 | 701.90 | 592.70 | 914.83 | 937.87 |
| Other operating income | 85.90 | 91.54 | |||
| Costs of manufacturing | - 710.27 | - 769.36 | |||
| External services | - 130.21 | - 126.03 | |||
| Gross profit | 1 002.39 | 701.90 | 592.70 | 160.25 | 134.02 |
| Employee benefit expenses | - 120.51 | - 124.13 | |||
| Other operating expenses | -0.00 | ||||
| Total depreciation | -0.53 | -0.51 | |||
| EBIT | -20.84 | -48.62 | -78.26 | 39.21 | 9.38 |
| Other financial income | 15.25 | 7.63 | |||
| Other financial expenses | -13.08 | -0.36 | |||
| Net income from associates (fin.) | 218.94 | ||||
| Pre-tax profit | 127.71 | 84.89 | 56.16 | 260.32 | 16.66 |
| Income taxes | -9.28 | -3.49 | |||
| Net earnings | 127.71 | 84.89 | 56.16 | 251.04 | 13.17 |
Assets (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 0.99 | 1.05 | |||
| Advance payments and construction in progress | 0.01 | 0.13 | |||
| Tangible assets total | 0.99 | 1.18 | |||
| Investments total | 820.85 | 906.82 | 942.62 | ||
| Non-current other receivables | 11.70 | 4.68 | |||
| Long term receivables total | 11.70 | 4.68 | |||
| Finished products/goods | 166.15 | 189.36 | |||
| Inventories total | 166.15 | 189.36 | |||
| Current trade debtors | 83.44 | 106.42 | |||
| Current amounts owed by group member comp. | 371.23 | 116.13 | |||
| Prepayments and accrued income | 2.61 | 3.09 | |||
| Current other receivables | 9.82 | 8.59 | |||
| Current deferred tax assets | 5.37 | 12.77 | |||
| Short term receivables total | 472.46 | 247.00 | |||
| Balance sheet total (assets) | 820.85 | 906.82 | 942.62 | 651.31 | 442.23 |
Equity and liabilities (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 148.87 | 233.76 | 289.92 | 14.00 | 14.00 |
| Shares repurchased | 300.00 | 100.00 | |||
| Retained earnings | - 127.71 | -84.89 | -56.16 | -24.08 | 126.96 |
| Profit of the financial year | 127.71 | 84.89 | 56.16 | 251.04 | 13.17 |
| Shareholders equity total | 148.87 | 233.76 | 289.92 | 540.96 | 254.12 |
| Provisions | 3.70 | 50.10 | |||
| Non-current deferred tax liabilities | 2.02 | 1.32 | |||
| Non-current liabilities total | 2.02 | 1.32 | |||
| Current loans from credit institutions | 0.88 | 2.48 | |||
| Current trade creditors | 37.88 | 16.12 | |||
| Current owed to group member | 2.62 | 52.14 | |||
| Short-term deferred tax liabilities | 0.80 | ||||
| Other non-interest bearing current liabilities | 63.25 | 65.14 | |||
| Current liabilities total | 104.63 | 136.68 | |||
| Balance sheet total (liabilities) | 148.87 | 233.76 | 289.92 | 651.31 | 442.23 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.